RExPO25

The International Conference on Systems Medicine, AI & Drug Repurposing
BarcelonaSeptember 24-26, 2025
PRBB - Barcelona Biomedical Research Park
About RExPO25
The fourth installment in the RExPO series
The REPO4EU Horizon Europe project currently building a European/Global Platform and Infrastructure for Drug Repurposing hosted its 4th International Conference on Systems Medicine, Artificial Intelligence and Drug Repurposing in Barcelona, Spain, from September 24-26, 2025.

120+
ATTENDEES

65+
SPEAKERS

13
POSTERS IN SHOW

65
PUBLICATIONS
The collection
Our ScienceOpen repository
All selected abstracts and presentations for RExPO25 have been published under a unique DOI at our online collection on ScienceOpen, as part of the conference’s proceedings – make sure to check out the full collection at the link below!
Network medicine
Network pharmacology
Precision diagnostics
Innovative trials
AI, LLMs & the EHDS
Drug reformulation
Patient-centered care
Implementation in healthcare
HTA reimbursement & payers
IP - Patenting or charity?
Regulatory science
Global impact & the UN Agenda 2030
RExPO26

The International Conference on Systems Medicine, AI & Drug Repurposing
BerlinSeptember 23-25, 2026
Futurium
Save the date
Join us this September 23–25 in Berlin for the fifth edition of RExPO, Europe’s leading conference in the intersection of systems medicine, network pharmacology, Artificial Intelligence and drug repurposing.
RExPO26 brings together clinicians, researchers, industry leaders, SMEs, patient organizations, regulators, payers and policymakers to shape the next generation of mechanism-based precision therapeutics.
Choose your spot
EARLY BIRD PRICES
Registration will open soon – stay tuned!
GENERAL ADMISSION
FULL PASS
400 EUR
GENERAL ADMISSION
2-DAY PASS
360 EUR
GENERAL ADMISSION
DAY PASS (LIMITED)
210 EUR
START-UPS
FULL PASS
300 EUR
START-UPS
2-DAY PASS
260 EUR
START-UPS
DAY PASS (LIMITED)
150 EUR
ACADEMIA
FULL PASS
250 EUR
ACADEMIA
2-DAY PASS
210 EUR
ACADEMIA
DAY PASS (LIMITED)
130 EUR
PHD STUDENTS
FULL PASS
150 EUR
PHD STUDENTS
2-DAY PASS
130 EUR
PHD STUDENTS
DAY PASS (LIMITED)
90 EUR
PATIENTS & PATIENT ORGANISATIONS
FULL PASS
75 EUR
PATIENTS & PATIENT ORGANISATIONS
2-DAY PASS
65 EUR
PATIENTS & PATIENT ORGANISATIONS
DAY PASS (LIMITED)
40 EUR
Conference tracks
Unmet medical needs in cancer
Unmet medical needs in neurological diseases
The REMEDi4ALL sister project
Innovation in drug development & repurposing
Network medicine approaches to adverse drug event prediction for new & repurposed drugs
Translating to the global market
AI/ML in systems medicine & drug repurposing
Fostering mechanism-based repurposing around the globe
REPO4EU's drug repurposing platform
The last mile: accessibility for patient benefit
Computational drug repurposing
The role of IP in the drug repurposing business case
The patients' voice and patient-centricity
What are you waiting for?
Meet a vibrant community of researchers, clinicians and innovators that are redefining precision medicine from mechanism to patient impact.
OUR SPEAKERS
Our call for abstracts is now open
If your abstract is selected, you’ll have the chance to present your work either during our dedicated Poster Sessions or as one of the conference’s Main Talks.
KEY TOPICS
REPO4EU's drug repurposing platform
Don't miss the official launch of our platform's beta version, first live presentation and hands-on demonstration.
The EU drug repurposing ecosystem
Meet all the major initiatives in drug repurposing (including REPO4EU, REMEDi4ALL and RePo-SUDOE) in one place.
Rare diseases & precision therapeutics
New translational strategies for rare and ultra-rare diseases, from mechanism discovery to targeted intervention.
The Network Medicine Alliance
Systems-level approaches to disease mechanisms, patient stratification and therapeutic innovation, plus a keynote lecture by Joseph Loscalzo, one of the founding figures of Network Medicine.
Generative AI & real-world applications
Gen AI use cases in systems medicine, biomarker discovery, hypothesis generation and clinical decision support.
Clinical trial validation & PoC studies
First validation results from REPO4EU-associated clinical studies and translational pilots.
Open Science, publishing & data sharing
New models for transparent science, FAIR data and dissemination in biomedical publishing.
IP strategy, reimbursement & sustainable market access
From intellectual property frameworks to payer acceptance, pricing and long-term implementation.
Useful information for attendees
Where will the conference take place?
RExPO26 will be held at Futurium. The venue’s full address is: Alexanderufer 2, 10117 Berlin, Germany.
How do I get in touch?
For any topic related to RExPO26, please feel free to contact the conference office. We will be happy to help – you can reach us directly via email.
000 days 00 hours 00 minutes 00 seconds
UNTIL RExPO26
In collaboration with...
Our Platinum Sponsor
Buchanan’s Life Sciences Industry Group offers a rare and comprehensive mix of FDA Regulatory, Intellectual Property, Litigation and Government Relations services delivered through one seamless team. They counsel clients on the full range of issues that arise during the product lifecycle, from idea conception to commercialization. Their clients, which include leading pharmaceutical companies, biotechnology companies, wholesalers and distributors, retailers, industry trade associations and leading research institutions, trust Buchanan Life Sciences with their most challenging business and legal problems.
RExPO24

The International Conference on Systems Medicine, AI & Drug Repurposing
MunichJuly 3-5, 2024
The Macherei München
About RExPO24
The third installment in the RExPO series
The REPO4EU Horizon Europe project currently building a European/Global Platform and Infrastructure for Drug Repurposing hosted its 3rd International Conference on Systems Medicine, Artificial Intelligence and Drug Repurposing in Munich, Germany, from July 3-5, 2024.

110+
ATTENDEES

40+
SPEAKERS

10
POSTERS IN SHOW

52
PUBLICATIONS
The collection
Our ScienceOpen repository
All selected abstracts and presentations for RExPO24 have been published under a unique DOI at our online collection on ScienceOpen, as part of the conference’s proceedings – make sure to check out the full collection at the link below!
Network medicine
Network pharmacology
Precision diagnostics
Innovative trials
AI, LLMs & the EHDS
Drug reformulation
Patient-centered care
Implementation in healthcare
HTA reimbursement & payers
IP - Patenting or charity?
Regulatory science
Global impact & the UN Agenda 2030
RExPO23

The International Conference on Systems Medicine, AI & Drug Repurposing
StockholmOctober 25-26, 2023
Elite Palace Hotel
About RExPO23
The second installment in the RExPO series
The REPO4EU Horizon Europe project currently building a European/Global Platform and Infrastructure for Drug Repurposing hosted its 2nd International Conference on Systems Medicine, Artificial Intelligence and Drug Repurposing in Stockholm, Sweden, from October 25-26, 2023.

115+
ATTENDEES

45+
SPEAKERS

8
POSTERS IN SHOW

51
PUBLICATIONS
The collection
Our ScienceOpen repository
All selected abstracts and presentations for RExPO23 have been published under a unique DOI at our online collection on ScienceOpen, as part of the conference’s proceedings – make sure to check out the full collection at the link below!
Network medicine
Network pharmacology
Precision diagnostics
Innovative trials
AI, LLMs & the EHDS
Drug reformulation
Patient-centered care
Implementation in healthcare
HTA reimbursement & payers
IP - Patenting or charity?
Regulatory science
Global impact & the UN Agenda 2030
RExPO Conference Series

The International Conference Series onSystems Medicine, AI & Drug Repurposing
Welcome to the drug repurposing revolution
Networking has always been the prime focus of any scientific and business event. RExPO is both, high impact science and innovative business. We have multiple collaborations around the world who pool together their knowledge and know-how to deliver the best possible outcome in the single major opportunity in drug development, i.e., drug repurposing. REPO4EU has partnered with professional societies, companies, patent attorneys, legal and ethics experts, clinical research organisations, regulators, payers, patient representatives and many more.
The RExPO conference is a one-of-a-kind opportunity to rank up knowledge and build up collaborations, creating, nurturing and expanding alliances in drug repurposing with world-class experts in the field.
RExPO22

The International Conference on Systems Medicine, AI & Drug Repurposing
MaastrichtSeptember 2-3, 2022
Maastricht School of Management
About RExPO22
Welcome to the drug repurposing revolution
The REPO4EU Horizon Europe project currently building a European/Global Platform and Infrastructure for Drug Repurposing officially kicked-off with the first International Conference on Systems Medicine, Artificial Intelligence and Drug Repurposing in Maastricht, The Netherlands, from September 2-3, 2022.

120+
ATTENDEES

40+
SPEAKERS

11
POSTERS IN SHOW

42
PUBLICATIONS
The collection
Our ScienceOpen repository
All selected abstracts and presentations for RExPO22 have been published under a unique DOI at our online collection on ScienceOpen, as part of the conference’s proceedings – make sure to check out the full collection at the link below!
Network medicine
Network pharmacology
Precision diagnostics
Innovative trials
AI, LLMs & the EHDS
Drug reformulation
Patient-centered care
Implementation in healthcare
HTA reimbursement & payers
IP - Patenting or charity?
Regulatory science
Global impact & the UN Agenda 2030
RExPO26 Abstracts

The International Conference on Systems Medicine, AI & Drug Repurposing
BerlinSeptember 23-25, 2026
Futurium
Want to showcase your work at RExPO26?
Submit your Abstract
RExPO26 will be a one-of-a-kind opportunity to rank up knowledge and build up collaborations. Come share your work with us and get the chance to interact with other experts on drug repurposing!
The agenda for RExPO26 is nearly final, with just a few slots open for late-breaking hot topics and posters.
Last chance to submit your abstract!
IN THE SPOTLIGHT
If your abstract is selected by our editorial committee, you’ll have the chance to participate in either our Main Talks or dedicated Poster Sessions.
OFFICIAL PUBLICATIONS
All selected abstracts and presentations will be published under a unique DOI in the RExPO26 online collection on the Drug Repurposing Central portal.
Learn how
OUR ABSTRACT GUIDELINES
All submissions will be carried out through our platform at ScienceOpen. Read on to learn how you can submit your abstract – all proposals will be considered for our dedicated Poster Sessions and some will be selected to be featured as Main Talks.
Only registered users can submit – make sure you are logged in before starting the submission process!
STEP 1
PREPARE YOUR SUBMISSION
Shape your conference submission according to the conference key topics. You’ll need to provide a brief abstract, keywords and references for your proposal.
STEP 2
START THE SUBMISSION PROCESS
Once your abstract is ready, follow the link below to our submission platform on Drug Repurposing Central. Click on the button in the header labeled “Submit your conference proceedings” to navigate to the submission form. Fill in all the required fields. Don’t forget to include the ORCID IDs of your co-authors, ROR IDs for affiliations and grant IDs and numbers.
STEP 3
YOUR ABSTRACT IS UNDER REVIEW
Abstracts will be carefully reviewed by our editorial team. Some of them may be selected as Main Talks for RExPO26 and added to our final agenda. All others will be showcased during our dedicated Poster Sessions.
STEP 4
GET READY FOR RExPO26
If your abstract is accepted, congratulations! The organizing committee will reach out to you to give you all the necessary details to make your RExPO26 experience a success!
THE RULES
Presenting authors for selected talks and/or posters are required to attend the conference in person and be available in time for the scheduled slot allocated to their talk and/or poster presentation.
Authors agree that their personal data (name and email address) will be temporarily stored, processed and used for the purpose of organizing the conference and managing poster abstract submissions. Personal data will be promptly deleted after the conference. Authors have the right to object to such use or processing of personal data at any time, by emailing their objection to rexpo@repo4.eu
THE TIMELINE
The deadline to submit your abstract is June 30, 2026
Please note: late submissions received after the deadline may be considered, but only if the topics proposed in the abstract are perceived as highly valuable towards the conference.
000 days 00 hours 00 minutes 00 seconds






















































































































